A detailed history of Citadel Investment Advisory, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Citadel Investment Advisory, Inc. holds 24,501 shares of JNJ stock, worth $3.8 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
24,501
Previous 24,001 2.08%
Holding current value
$3.8 Million
Previous $3.51 Million 13.17%
% of portfolio
2.16%
Previous 1.99%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $72,740 - $83,690
500 Added 2.08%
24,501 $3.97 Million
Q1 2024

Apr 17, 2024

SELL
$155.22 - $162.74 $26,697 - $27,991
-172 Reduced 0.71%
24,001 $3.8 Million
Q4 2023

Jan 23, 2024

SELL
$145.6 - $158.88 $1,456 - $1,588
-10 Reduced 0.04%
24,173 $3.79 Million
Q2 2023

Jul 11, 2023

SELL
$154.35 - $166.11 $23,152 - $24,916
-150 Reduced 0.62%
24,183 $4 Million
Q1 2023

May 01, 2023

SELL
$151.05 - $180.26 $18,126 - $21,631
-120 Reduced 0.49%
24,333 $3.77 Million
Q4 2022

Jan 18, 2023

SELL
$160.2 - $179.79 $38,448 - $43,149
-240 Reduced 0.97%
24,453 $4.32 Million
Q3 2022

Oct 20, 2022

SELL
$161.33 - $179.52 $8,066 - $8,976
-50 Reduced 0.2%
24,693 $4.03 Million
Q2 2022

Aug 02, 2022

SELL
$168.19 - $186.01 $138,756 - $153,458
-825 Reduced 3.23%
24,743 $4.39 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $124,139 - $140,978
785 Added 3.17%
25,568 $4.53 Million
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $19,491 - $21,626
-125 Reduced 0.5%
24,783 $4.24 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $41,464 - $44,478
-260 Reduced 1.03%
24,908 $4.1 Million
Q1 2021

Apr 20, 2021

BUY
$153.07 - $170.48 $273,383 - $304,477
1,786 Added 7.64%
25,168 $4.14 Million
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $3.21 Million - $3.68 Million
23,382 New
23,382 $3.97 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Citadel Investment Advisory, Inc. Portfolio

Follow Citadel Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Citadel Investment Advisory, Inc. with notifications on news.